George Farmer
Stock Analyst at Scotiabank
(1.79)
# 3,379
Out of 5,238 analysts
66
Total ratings
47.06%
Success rate
-1.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Maintains: Sector Outperform | $30 → $10 | $1.54 | +549.35% | 4 | Aug 6, 2025 | |
| INMB INmune Bio | Downgrades: Sector Underperform | $23 → $0.6 | $1.43 | -58.04% | 3 | Jul 1, 2025 | |
| URGN UroGen Pharma | Maintains: Sector Outperform | $23 → $47 | $29.40 | +59.86% | 1 | Jun 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $21.49 | -20.89% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $5.27 | +127.70% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $1.99 | +352.26% | 4 | Apr 10, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $14.18 | +189.24% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $38.73 | +34.26% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $54.06 | +47.98% | 8 | Feb 20, 2025 | |
| BIIB Biogen | Maintains: Sector Outperform | $244 → $224 | $193.45 | +15.79% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $102 | $31.33 | +225.57% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $9.42 | +6.16% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $782.17 | -8.59% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $8.40 | +173.81% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $0.86 | +2,218.30% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $28.12 | +170.27% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $5.90 | +120.34% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $54.35 | +100.55% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $98.56 | -11.73% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $2.95 | +1,018.64% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $400 | $11.63 | +3,339.38% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $48.16 | -43.94% | 3 | May 6, 2020 |
Biomea Fusion
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $30 → $10
Current: $1.54
Upside: +549.35%
INmune Bio
Jul 1, 2025
Downgrades: Sector Underperform
Price Target: $23 → $0.6
Current: $1.43
Upside: -58.04%
UroGen Pharma
Jun 13, 2025
Maintains: Sector Outperform
Price Target: $23 → $47
Current: $29.40
Upside: +59.86%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $21.49
Upside: -20.89%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $5.27
Upside: +127.70%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $1.99
Upside: +352.26%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $14.18
Upside: +189.24%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $38.73
Upside: +34.26%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $54.06
Upside: +47.98%
Biogen
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $193.45
Upside: +15.79%
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $31.33
Upside: +225.57%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $9.42
Upside: +6.16%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $782.17
Upside: -8.59%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $8.40
Upside: +173.81%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $0.86
Upside: +2,218.30%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $28.12
Upside: +170.27%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $5.90
Upside: +120.34%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $54.35
Upside: +100.55%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $98.56
Upside: -11.73%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $2.95
Upside: +1,018.64%
Jul 20, 2020
Initiates: Outperform
Price Target: $400
Current: $11.63
Upside: +3,339.38%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $48.16
Upside: -43.94%